1. Volume 375, Issue 9728, Pages 1798-1807 (May 2010)
Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study 
Dr Keertan Dheda, PhD, Karen Shean, MSc, Prof Alimuddin Zumla, FRCP, Motasim Badri, PhD, Elizabeth M Streicher, PhD, Liesl Page- Shipp, MBBCh, Paul Willcox, FCP, Melanie-Anne John, FCPath, Gary Reubenson, FCP, Darshini Govindasamy, BSc, Prof Michelle Wong, PhD, Xavier Padanilam, MCFP, Alicia Dziwiecki, MD, Prof Paul D van Helden, PhD, Sweetness Siwendu, MBChB, Julie Jarand, MD, Colin N Menezes, FCP, Avril Burns, BA, Prof Thomas Victor, PhD, Prof Robin Warren, PhD, Prof Martin P Grobusch, PhD, Martie van der Walt, PhD, Charlotte Kvasnovsky, BSc 
The Lancet 
Volume 375, Issue 9728, Pages (May 2010)
DOI: /S (10)
Copyright © 2010 Elsevier Ltd Terms and Conditions

2. Figure 1
Study profile (A), and timeline for data gathering stratified by recruitment institution (B)
MDR=multidrug-resistant. XDR=extensively drug-resistant. *Local approval was only obtained for this period.
The Lancet  , DOI: ( /S (10) )
Copyright © 2010 Elsevier Ltd Terms and Conditions

3. Figure 2
Kaplan-Meier estimates of culture-conversion and deaths in patients with extensively drug-resistant tuberculosis
(A) Probabilities of culture conversion in patients with and without HIV infection given treatment; (B) probabilities of death in patients who died before initiation of treatment stratified by HIV status; (C) probabilities of death in patients with and without HIV infection given treatment from date of treatment initiation; and (D) probabilities of death in patients with HIV infection given treatment stratified according to use of highly active antiretroviral therapy.
The Lancet  , DOI: ( /S (10) )
Copyright © 2010 Elsevier Ltd Terms and Conditions